Požymis
Anxiety
Intense feelings of nervousness, tension, or panic often arise in response to interpersonal stresses. There is worry about the negative effects of past unpleasant experiences and future negative possibilities. Individuals may feel fearful, apprehensive, or threatened by uncertainty, and they may also have fears of falling apart or losing control.
Santrauka
- Taip pat vadinama
- Anxiety disease, Excessive, persistent worry and fear, Anxiousness
- Kūno sistema
- Abnormality of the nervous system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Anxiety, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test501 genas susijęs su Anxiety
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Anxiety. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ABCC9ATP binding cassette subfamily C member 9 | Visada | 1 ligoje |
| ADCY5adenylate cyclase 5 | Visada | 2 ligose |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Visada | 1 ligoje |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Visada | 1 ligoje |
| ASH1LASH1 like histone lysine methyltransferase | Visada | 1 ligoje |
| CACHD1cache domain containing 1 | Visada | 1 ligoje |
| CST3cystatin C | Visada | 1 ligoje |
| EIF2AK1eukaryotic translation initiation factor 2 alpha kinase 1 | Visada | 1 ligoje |
| EMC10ER membrane protein complex subunit 10 | Visada | 1 ligoje |
| FDXRferredoxin reductase | Visada | 1 ligoje |
| FOXP1forkhead box P1 | Visada | 2 ligose |
| FRYLFRY like transcription coactivator | Visada | 1 ligoje |
| HTRA1HtrA serine peptidase 1 | Visada | 1 ligoje |
| KDM6Blysine demethylase 6B | Visada | 1 ligoje |
| LRRC7leucine rich repeat containing 7 | Visada | 1 ligoje |
| LSM7LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated | Visada | 1 ligoje |
| MARK2microtubule affinity regulating kinase 2 | Visada | 1 ligoje |
| MAU2MAU2 sister chromatid cohesion factor | Visada | 2 ligose |
| MED16mediator complex subunit 16 | Visada | 1 ligoje |
| NAV3neuron navigator 3 | Visada | 1 ligoje |
| NFIXnuclear factor I X | Visada | 2 ligose |
| NSD2nuclear receptor binding SET domain protein 2 | Visada | 1 ligoje |
| PARK7Parkinsonism associated deglycase | Visada | 2 ligose |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Visada | 1 ligoje |
| POLG2DNA polymerase gamma 2, accessory subunit | Visada | 2 ligose |
| RAB32RAB32, member RAS oncogene family | Visada | 1 ligoje |
| RAB3ARAB3A, member RAS oncogene family | Visada | 1 ligoje |
| RNU4-2RNA, U4 small nuclear 2 | Visada | 1 ligoje |
| SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor | Visada | 1 ligoje |
| SLC13A1solute carrier family 13 member 1 | Visada | 1 ligoje |
| UBR5ubiquitin protein ligase E3 component n-recognin 5 | Visada | 1 ligoje |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Visada | 1 ligoje |
| UNC13Aunc-13 homolog A | Visada | 2 ligose |
| UQCRC1ubiquinol-cytochrome c reductase core protein 1 | Visada | 1 ligoje |
| YWHAZtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | Visada | 1 ligoje |
| AGO1argonaute RISC component 1 | Labai dažnai (80–99%) | 1 ligoje |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Labai dažnai (80–99%) | 1 ligoje |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Labai dažnai (80–99%) | 1 ligoje |
| CASRcalcium sensing receptor | Labai dažnai (80–99%) | 1 ligoje |
| CLIP2CAP-Gly domain containing linker protein 2 | Labai dažnai (80–99%) | 1 ligoje |
Rodyti dar 461 geną
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| CLTRNcollectrin, amino acid transport regulator | Labai dažnai (80–99%) | 1 ligoje |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Labai dažnai (80–99%) | 1 ligoje |
| EIF4Heukaryotic translation initiation factor 4H | Labai dažnai (80–99%) | 1 ligoje |
| ELNelastin | Labai dažnai (80–99%) | 2 ligose |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Labai dažnai (80–99%) | 1 ligoje |
| GNA11G protein subunit alpha 11 | Labai dažnai (80–99%) | 1 ligoje |
| GTF2Igeneral transcription factor IIi | Labai dažnai (80–99%) | 1 ligoje |
| GTF2IRD1GTF2I repeat domain containing 1 | Labai dažnai (80–99%) | 1 ligoje |
| GTF2IRD2GTF2I repeat domain containing 2 | Labai dažnai (80–99%) | 1 ligoje |
| KPTNkaptin, actin binding protein | Labai dažnai (80–99%) | 2 ligose |
| LIMK1LIM domain kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| METTL27methyltransferase like 27 | Labai dažnai (80–99%) | 1 ligoje |
| MLXIPLMLX interacting protein like | Labai dažnai (80–99%) | 1 ligoje |
| NCF1neutrophil cytosolic factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Labai dažnai (80–99%) | 1 ligoje |
| PHF21APHD finger protein 21A | Labai dažnai (80–99%) | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Labai dažnai (80–99%) | 5 ligose |
| RAI1retinoic acid induced 1 | Labai dažnai (80–99%) | 2 ligose |
| RFC2replication factor C subunit 2 | Labai dažnai (80–99%) | 1 ligoje |
| SLC6A19solute carrier family 6 member 19 | Labai dažnai (80–99%) | 1 ligoje |
| SLITRK2SLIT and NTRK like family member 2 | Labai dažnai (80–99%) | 1 ligoje |
| STX1Asyntaxin 1A | Labai dažnai (80–99%) | 2 ligose |
| TBL2transducin beta like 2 | Labai dažnai (80–99%) | 1 ligoje |
| TMEM270transmembrane protein 270 | Labai dažnai (80–99%) | 1 ligoje |
| VPS37DVPS37D subunit of ESCRT-I | Labai dažnai (80–99%) | 1 ligoje |
| WFS1wolframin ER transmembrane glycoprotein | Labai dažnai (80–99%) | 2 ligose |
| ADNPactivity dependent neuroprotector homeobox | Dažnai (30–79%) | 2 ligose |
| AHDC1AT-hook DNA binding motif containing 1 | Dažnai (30–79%) | 1 ligoje |
| AIPAHR interacting HSP90 co-chaperone | Dažnai (30–79%) | 1 ligoje |
| ANGangiogenin | Dažnai (30–79%) | 1 ligoje |
| ANXA11annexin A11 | Dažnai (30–79%) | 1 ligoje |
| ARandrogen receptor | Dažnai (30–79%) | 2 ligose |
| ARVCFARVCF delta catenin family member | Dažnai (30–79%) | 1 ligoje |
| ATMATM serine/threonine kinase | Dažnai (30–79%) | 1 ligoje |
| ATXN2ataxin 2 | Dažnai (30–79%) | 1 ligoje |
| BMPR1Abone morphogenetic protein receptor type 1A | Dažnai (30–79%) | 1 ligoje |
| BPTFbromodomain PHD finger transcription factor | Dažnai (30–79%) | 1 ligoje |
| BRCA2BRCA2 DNA repair associated | Dažnai (30–79%) | 1 ligoje |
| BRD4bromodomain containing 4 | Dažnai (30–79%) | 1 ligoje |
| C1Rcomplement C1r | Dažnai (30–79%) | 1 ligoje |
| C1Scomplement C1s | Dažnai (30–79%) | 1 ligoje |
| CCNFcyclin F | Dažnai (30–79%) | 1 ligoje |
| CDKN2Acyclin dependent kinase inhibitor 2A | Dažnai (30–79%) | 1 ligoje |
| CDONcell adhesion associated, oncogene regulated | Dažnai (30–79%) | 4 ligose |
| CFAP410cilia and flagella associated protein 410 | Dažnai (30–79%) | 1 ligoje |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Dažnai (30–79%) | 1 ligoje |
| CHD7chromodomain helicase DNA binding protein 7 | Dažnai (30–79%) | 1 ligoje |
| CHD8chromodomain helicase DNA binding protein 8 | Dažnai (30–79%) | 1 ligoje |
| CHEK2checkpoint kinase 2 | Dažnai (30–79%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Dažnai (30–79%) | 2 ligose |
| CLCN3Cl-/H+ antiporter 3 | Dažnai (30–79%) | 1 ligoje |
| CMPK2cytidine/uridine monophosphate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| COL7A1collagen type VII alpha 1 chain | Dažnai (30–79%) | 2 ligose |
| COMTcatechol-O-methyltransferase | Dažnai (30–79%) | 1 ligoje |
| COQ2coenzyme Q2, polyprenyltransferase | Dažnai (30–79%) | 2 ligose |
| CRIPTOcripto, EGF-CFC family member | Dažnai (30–79%) | 4 ligose |
| CTNNB1catenin beta 1 | Dažnai (30–79%) | 1 ligoje |
| CTSHcathepsin H | Dažnai (30–79%) | 1 ligoje |
| DAOD-amino acid oxidase | Dažnai (30–79%) | 1 ligoje |
| DCTN1dynactin subunit 1 | Dažnai (30–79%) | 2 ligose |
| DENND5ADENN domain containing 5A | Dažnai (30–79%) | 1 ligoje |
| DISP1dispatched RND transporter family member 1 | Dažnai (30–79%) | 4 ligose |
| DLL1delta like canonical Notch ligand 1 | Dažnai (30–79%) | 4 ligose |
| DRD2dopamine receptor D2 | Dažnai (30–79%) | 1 ligoje |
| DUSP6dual specificity phosphatase 6 | Dažnai (30–79%) | 1 ligoje |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Dažnai (30–79%) | 2 ligose |
| EMX2empty spiracles homeobox 2 | Dažnai (30–79%) | 1 ligoje |
| EPCAMepithelial cell adhesion molecule | Dažnai (30–79%) | 1 ligoje |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| FAM177A1family with sequence similarity 177 member A1 | Dažnai (30–79%) | 1 ligoje |
| FEM1Bfem-1 homolog B | Dažnai (30–79%) | 1 ligoje |
| FGF17fibroblast growth factor 17 | Dažnai (30–79%) | 1 ligoje |
| FGF8fibroblast growth factor 8 | Dažnai (30–79%) | 5 ligose |
| FGFR1fibroblast growth factor receptor 1 | Dažnai (30–79%) | 3 ligose |
| FIG4FIG4 phosphoinositide 5-phosphatase | Dažnai (30–79%) | 1 ligoje |
| FLT4fms related receptor tyrosine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| FMR1fragile X messenger ribonucleoprotein 1 | Dažnai (30–79%) | 3 ligose |
| FOXH1forkhead box H1 | Dažnai (30–79%) | 4 ligose |
| FUSFUS RNA binding protein | Dažnai (30–79%) | 1 ligoje |
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Dažnai (30–79%) | 2 ligose |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Dažnai (30–79%) | 4 ligose |
| GAS1growth arrest specific 1 | Dažnai (30–79%) | 4 ligose |
| GCH1GTP cyclohydrolase 1 | Dažnai (30–79%) | 1 ligoje |
| GLE1GLE1 RNA export mediator | Dažnai (30–79%) | 1 ligoje |
| GLI2GLI family zinc finger 2 | Dažnai (30–79%) | 4 ligose |
| GLT8D1glycosyltransferase 8 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GM2Aganglioside GM2 activator | Dažnai (30–79%) | 1 ligoje |
| GNRH1gonadotropin releasing hormone 1 | Dažnai (30–79%) | 1 ligoje |
| GNRHRgonadotropin releasing hormone receptor | Dažnai (30–79%) | 1 ligoje |
| GP1BBglycoprotein Ib platelet subunit beta | Dažnai (30–79%) | 1 ligoje |
| GPR101G protein-coupled receptor 101 | Dažnai (30–79%) | 1 ligoje |
| GRNgranulin precursor | Dažnai (30–79%) | 1 ligoje |
| HCRThypocretin neuropeptide precursor | Dažnai (30–79%) | 1 ligoje |
| HDAC8histone deacetylase 8 | Dažnai (30–79%) | 1 ligoje |
| HIRAhistone cell cycle regulator | Dažnai (30–79%) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Dažnai (30–79%) | 3 ligose |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Dažnai (30–79%) | 1 ligoje |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Dažnai (30–79%) | 1 ligoje |
| HNRNPH2heterogeneous nuclear ribonucleoprotein H2 | Dažnai (30–79%) | 1 ligoje |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Dažnai (30–79%) | 1 ligoje |
| HTThuntingtin | Dažnai (30–79%) | 1 ligoje |
| IMPDH2inosine monophosphate dehydrogenase 2 | Dažnai (30–79%) | 1 ligoje |
| JAM2junctional adhesion molecule 2 | Dažnai (30–79%) | 1 ligoje |
| JMJD1Cjumonji domain containing 1C | Dažnai (30–79%) | 1 ligoje |
| KCNN2potassium calcium-activated channel subfamily N member 2 | Dažnai (30–79%) | 1 ligoje |
| KCTD17potassium channel tetramerization domain containing 17 | Dažnai (30–79%) | 2 ligose |
| KISS1KiSS-1 metastasis suppressor | Dažnai (30–79%) | 1 ligoje |
| KISS1RKISS1 receptor | Dažnai (30–79%) | 1 ligoje |
| KMT2Alysine methyltransferase 2A | Dažnai (30–79%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Dažnai (30–79%) | 1 ligoje |
| LARP7La ribonucleoprotein 7, transcriptional regulator | Dažnai (30–79%) | 2 ligose |
| LRP12LDL receptor related protein 12 | Dažnai (30–79%) | 1 ligoje |
| MAPTmicrotubule associated protein tau | Dažnai (30–79%) | 2 ligose |
| MATR3matrin 3 | Dažnai (30–79%) | 1 ligoje |
| MBD5methyl-CpG binding domain protein 5 | Dažnai (30–79%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| MLH1mutL homolog 1 | Dažnai (30–79%) | 1 ligoje |
| MMP1matrix metallopeptidase 1 | Dažnai (30–79%) | 1 ligoje |
| MOGmyelin oligodendrocyte glycoprotein | Dažnai (30–79%) | 1 ligoje |
| MSH2mutS homolog 2 | Dažnai (30–79%) | 1 ligoje |
| MSH6mutS homolog 6 | Dažnai (30–79%) | 1 ligoje |
| MSL2MSL complex subunit 2 | Dažnai (30–79%) | 1 ligoje |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Dažnai (30–79%) | 2 ligose |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Dažnai (30–79%) | 1 ligoje |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Dažnai (30–79%) | 1 ligoje |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Dažnai (30–79%) | 1 ligoje |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Dažnai (30–79%) | 1 ligoje |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Dažnai (30–79%) | 1 ligoje |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Dažnai (30–79%) | 1 ligoje |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Dažnai (30–79%) | 1 ligoje |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Dažnai (30–79%) | 1 ligoje |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Dažnai (30–79%) | 1 ligoje |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Dažnai (30–79%) | 1 ligoje |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Dažnai (30–79%) | 1 ligoje |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Dažnai (30–79%) | 1 ligoje |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Dažnai (30–79%) | 2 ligose |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Dažnai (30–79%) | 1 ligoje |
| MUTYHmutY DNA glycosylase | Dažnai (30–79%) | 1 ligoje |
| MYORGmyogenesis regulating glycosidase | Dažnai (30–79%) | 1 ligoje |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Dažnai (30–79%) | 2 ligose |
| NDC1NDC1 transmembrane nucleoporin | Dažnai (30–79%) | 1 ligoje |
| NDPnorrin cystine knot growth factor NDP | Dažnai (30–79%) | 1 ligoje |
| NEFHneurofilament heavy chain | Dažnai (30–79%) | 1 ligoje |
| NEK1NIMA related kinase 1 | Dažnai (30–79%) | 1 ligoje |
| NHLH2nescient helix-loop-helix 2 | Dažnai (30–79%) | 1 ligoje |
| NIPBLNIPBL cohesin loading factor | Dažnai (30–79%) | 2 ligose |
| NODALnodal growth differentiation factor | Dažnai (30–79%) | 4 ligose |
| NONOnon-POU domain containing octamer binding | Dažnai (30–79%) | 1 ligoje |
| NPATnuclear protein, coactivator of histone transcription | Dažnai (30–79%) | 1 ligoje |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Dažnai (30–79%) | 1 ligoje |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Dažnai (30–79%) | 1 ligoje |
| OPTNoptineurin | Dažnai (30–79%) | 1 ligoje |
| P2RY11purinergic receptor P2Y11 | Dažnai (30–79%) | 1 ligoje |
| PCDH19protocadherin 19 | Dažnai (30–79%) | 2 ligose |
| PDGFBplatelet derived growth factor subunit B | Dažnai (30–79%) | 2 ligose |
| PDGFRBplatelet derived growth factor receptor beta | Dažnai (30–79%) | 2 ligose |
| PFN1profilin 1 | Dažnai (30–79%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Dažnai (30–79%) | 1 ligoje |
| PLCH1phospholipase C eta 1 | Dažnai (30–79%) | 1 ligoje |
| PMS1PMS1 homolog 1, mismatch repair system component | Dažnai (30–79%) | 1 ligoje |
| PMS2PMS1 homolog 2, mismatch repair system component | Dažnai (30–79%) | 1 ligoje |
| POGZpogo transposable element derived with ZNF domain | Dažnai (30–79%) | 1 ligoje |
| POLD1DNA polymerase delta 1, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| POLEDNA polymerase epsilon, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Dažnai (30–79%) | 2 ligose |
| PPFIA3PPFI scaffold protein A3 | Dažnai (30–79%) | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Dažnai (30–79%) | 1 ligoje |
| PPP1CBprotein phosphatase 1 catalytic subunit beta | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 2 ligose |
| PRKAR1Bprotein kinase cAMP-dependent type I regulatory subunit beta | Dažnai (30–79%) | 1 ligoje |
| PROK2prokineticin 2 | Dažnai (30–79%) | 1 ligoje |
| PROKR2prokineticin receptor 2 | Dažnai (30–79%) | 1 ligoje |
| PRPHperipherin | Dažnai (30–79%) | 1 ligoje |
| PRR12proline rich 12 | Dažnai (30–79%) | 1 ligoje |
| PSEN1presenilin 1 | Dažnai (30–79%) | 1 ligoje |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Dažnai (30–79%) | 1 ligoje |
| PTCH1patched 1 | Dažnai (30–79%) | 4 ligose |
| PTRHD1peptidyl-tRNA hydrolase domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| RAD21RAD21 cohesin complex component | Dažnai (30–79%) | 1 ligoje |
| RPS20ribosomal protein S20 | Dažnai (30–79%) | 1 ligoje |
| RREB1ras responsive element binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| RRP12ribosomal RNA processing 12 homolog | Dažnai (30–79%) | 2 ligose |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Dažnai (30–79%) | 2 ligose |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Dažnai (30–79%) | 2 ligose |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Dažnai (30–79%) | 2 ligose |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Dažnai (30–79%) | 2 ligose |
| SEC24CSEC24 homolog C, COPII component | Dažnai (30–79%) | 1 ligoje |
| SEMA4Asemaphorin 4A | Dažnai (30–79%) | 1 ligoje |
| SETD1BSET domain containing 1B, histone lysine methyltransferase | Dažnai (30–79%) | 1 ligoje |
| SGCEsarcoglycan epsilon | Dažnai (30–79%) | 2 ligose |
| SHHsonic hedgehog signaling molecule | Dažnai (30–79%) | 4 ligose |
| SIX3SIX homeobox 3 | Dažnai (30–79%) | 4 ligose |
| SLC20A2solute carrier family 20 member 2 | Dažnai (30–79%) | 1 ligoje |
| SLC2A3solute carrier family 2 member 3 | Dažnai (30–79%) | 1 ligoje |
| SLC35C1solute carrier family 35 member C1 | Dažnai (30–79%) | 1 ligoje |
| SMC1Astructural maintenance of chromosomes 1A | Dažnai (30–79%) | 2 ligose |
| SMC3structural maintenance of chromosomes 3 | Dažnai (30–79%) | 1 ligoje |
| SMC5structural maintenance of chromosomes 5 | Dažnai (30–79%) | 1 ligoje |
| SOD1superoxide dismutase 1 | Dažnai (30–79%) | 1 ligoje |
| SOX5SRY-box transcription factor 5 | Dažnai (30–79%) | 2 ligose |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Dažnai (30–79%) | 1 ligoje |
| SPRY4sprouty RTK signaling antagonist 4 | Dažnai (30–79%) | 1 ligoje |
| SQSTM1sequestosome 1 | Dažnai (30–79%) | 1 ligoje |
| STAG2STAG2 cohesin complex component | Dažnai (30–79%) | 3 ligose |
| STILSTIL centriolar assembly protein | Dažnai (30–79%) | 4 ligose |
| STUB1STIP1 homology and U-box containing protein 1 | Dažnai (30–79%) | 1 ligoje |
| TAC3tachykinin precursor 3 | Dažnai (30–79%) | 1 ligoje |
| TACR3tachykinin receptor 3 | Dažnai (30–79%) | 1 ligoje |
| TAF1TATA-box binding protein associated factor 1 | Dažnai (30–79%) | 1 ligoje |
| TAF15TATA-box binding protein associated factor 15 | Dažnai (30–79%) | 1 ligoje |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Dažnai (30–79%) | 1 ligoje |
| TANC2tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 | Dažnai (30–79%) | 1 ligoje |
| TARDBPTAR DNA binding protein | Dažnai (30–79%) | 1 ligoje |
| TBCBtubulin folding cofactor B | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TBX1T-box transcription factor 1 | Dažnai (30–79%) | 2 ligose |
| TERTtelomerase reverse transcriptase | Dažnai (30–79%) | 1 ligoje |
| TET3tet methylcytosine dioxygenase 3 | Dažnai (30–79%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Dažnai (30–79%) | 1 ligoje |
| TGIF1TGFB induced factor homeobox 1 | Dažnai (30–79%) | 4 ligose |
| THRBthyroid hormone receptor beta | Dažnai (30–79%) | 1 ligoje |
| TLK2tousled like kinase 2 | Dažnai (30–79%) | 1 ligoje |
| TLR7toll like receptor 7 | Dažnai (30–79%) | 1 ligoje |
| TM2D3TM2 domain containing 3 | Dažnai (30–79%) | 1 ligoje |
| TMCO1transmembrane and coiled-coil domains 1 | Dažnai (30–79%) | 1 ligoje |
| TMEM106Btransmembrane protein 106B | Dažnai (30–79%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Dažnai (30–79%) | 1 ligoje |
| TOR1Atorsin family 1 member A | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 1 ligoje |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Dažnai (30–79%) | 1 ligoje |
| TREM2triggering receptor expressed on myeloid cells 2 | Dažnai (30–79%) | 2 ligose |
| UBAP2Lubiquitin associated protein 2 like | Dažnai (30–79%) | 1 ligoje |
| UBQLN2ubiquilin 2 | Dažnai (30–79%) | 1 ligoje |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Dažnai (30–79%) | 1 ligoje |
| VAPBVAMP associated protein B and C | Dažnai (30–79%) | 1 ligoje |
| VCPvalosin containing protein | Dažnai (30–79%) | 3 ligose |
| VPS13Avacuolar protein sorting 13 homolog A | Dažnai (30–79%) | 2 ligose |
| WACWW domain containing adaptor with coiled-coil | Dažnai (30–79%) | 3 ligose |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Dažnai (30–79%) | 1 ligoje |
| WDR11WD repeat domain 11 | Dažnai (30–79%) | 1 ligoje |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Dažnai (30–79%) | 1 ligoje |
| ZIC2Zic family zinc finger 2 | Dažnai (30–79%) | 4 ligose |
| ZNF365zinc finger protein 365 | Dažnai (30–79%) | 1 ligoje |
| ZNRF3zinc and ring finger 3 | Dažnai (30–79%) | 1 ligoje |
| ACSL4acyl-CoA synthetase long chain family member 4 | Kartais (5–29%) | 1 ligoje |
| ADGRV1adhesion G protein-coupled receptor V1 | Kartais (5–29%) | 2 ligose |
| ALADaminolevulinate dehydratase | Kartais (5–29%) | 1 ligoje |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Kartais (5–29%) | 1 ligoje |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Kartais (5–29%) | 1 ligoje |
| APC2APC regulator of Wnt signaling pathway 2 | Kartais (5–29%) | 1 ligoje |
| ARID2AT-rich interaction domain 2 | Kartais (5–29%) | 1 ligoje |
| ARL6ARF like GTPase 6 | Kartais (5–29%) | 1 ligoje |
| ARSGarylsulfatase G | Kartais (5–29%) | 1 ligoje |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Kartais (5–29%) | 1 ligoje |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Kartais (5–29%) | 2 ligose |
| ATP7BATPase copper transporting beta | Kartais (5–29%) | 1 ligoje |
| BBIP1BBSome interacting protein 1 | Kartais (5–29%) | 1 ligoje |
| BBS1Bardet-Biedl syndrome 1 | Kartais (5–29%) | 1 ligoje |
| BBS10Bardet-Biedl syndrome 10 | Kartais (5–29%) | 1 ligoje |
| BBS12Bardet-Biedl syndrome 12 | Kartais (5–29%) | 1 ligoje |
| BBS2Bardet-Biedl syndrome 2 | Kartais (5–29%) | 1 ligoje |
| BBS4Bardet-Biedl syndrome 4 | Kartais (5–29%) | 1 ligoje |
| BBS5Bardet-Biedl syndrome 5 | Kartais (5–29%) | 1 ligoje |
| BBS7Bardet-Biedl syndrome 7 | Kartais (5–29%) | 1 ligoje |
| BBS9Bardet-Biedl syndrome 9 | Kartais (5–29%) | 1 ligoje |
| BCL11BBCL11 transcription factor B | Kartais (5–29%) | 1 ligoje |
| CABP4calcium binding protein 4 | Kartais (5–29%) | 1 ligoje |
| CACNA1Hcalcium voltage-gated channel subunit alpha1 H | Kartais (5–29%) | 1 ligoje |
| CAPRIN1cell cycle associated protein 1 | Kartais (5–29%) | 1 ligoje |
| CBScystathionine beta-synthase | Kartais (5–29%) | 1 ligoje |
| CCND1cyclin D1 | Kartais (5–29%) | 1 ligoje |
| CDC42BPBCDC42 binding protein kinase beta | Kartais (5–29%) | 1 ligoje |
| CDH2cadherin 2 | Kartais (5–29%) | 1 ligoje |
| CDH23cadherin related 23 | Kartais (5–29%) | 1 ligoje |
| CEACAM3CEA cell adhesion molecule 3 | Kartais (5–29%) | 1 ligoje |
| CEACAM6CEA cell adhesion molecule 6 | Kartais (5–29%) | 1 ligoje |
| CEP19centrosomal protein 19 | Kartais (5–29%) | 1 ligoje |
| CEP290centrosomal protein 290 | Kartais (5–29%) | 1 ligoje |
| CEP78centrosomal protein 78 | Kartais (5–29%) | 1 ligoje |
| CFAP418cilia and flagella associated protein 418 | Kartais (5–29%) | 1 ligoje |
| CFTRCF transmembrane conductance regulator | Kartais (5–29%) | 1 ligoje |
| CHRNA2cholinergic receptor nicotinic alpha 2 subunit | Kartais (5–29%) | 1 ligoje |
| CHRNA4cholinergic receptor nicotinic alpha 4 subunit | Kartais (5–29%) | 1 ligoje |
| CHRNB2cholinergic receptor nicotinic beta 2 subunit | Kartais (5–29%) | 1 ligoje |
| CICcapicua transcriptional repressor | Kartais (5–29%) | 1 ligoje |
| CLCA4chloride channel accessory 4 | Kartais (5–29%) | 1 ligoje |
| CLCN4Cl-/H+ antiporter 4 | Kartais (5–29%) | 2 ligose |
| CLRN1clarin 1 | Kartais (5–29%) | 1 ligoje |
| CRHcorticotropin releasing hormone | Kartais (5–29%) | 1 ligoje |
| CTCFCCCTC-binding factor | Kartais (5–29%) | 1 ligoje |
| DCTN4dynactin subunit 4 | Kartais (5–29%) | 1 ligoje |
| DDB1damage specific DNA binding protein 1 | Kartais (5–29%) | 1 ligoje |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Kartais (5–29%) | 1 ligoje |
| DLATdihydrolipoamide S-acetyltransferase | Kartais (5–29%) | 1 ligoje |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Kartais (5–29%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Kartais (5–29%) | 1 ligoje |
| DPH1diphthamide biosynthesis 1 | Kartais (5–29%) | 1 ligoje |
| DPH2diphthamide biosynthesis 2 | Kartais (5–29%) | 1 ligoje |
| EDNRAendothelin receptor type A | Kartais (5–29%) | 1 ligoje |
| EFHC1EF-hand domain containing 1 | Kartais (5–29%) | 1 ligoje |
| EHMT1euchromatic histone lysine methyltransferase 1 | Kartais (5–29%) | 2 ligose |
| ESPNespin | Kartais (5–29%) | 1 ligoje |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Kartais (5–29%) | 1 ligoje |
| FRMD5FERM domain containing 5 | Kartais (5–29%) | 1 ligoje |
| FTSJ1FtsJ RNA 2'-O-methyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| FXNfrataxin | Kartais (5–29%) | 1 ligoje |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Kartais (5–29%) | 1 ligoje |
| GALTgalactose-1-phosphate uridylyltransferase | Kartais (5–29%) | 1 ligoje |
| GCLCglutamate-cysteine ligase catalytic subunit | Kartais (5–29%) | 1 ligoje |
| GLAgalactosidase alpha | Kartais (5–29%) | 1 ligoje |
| GNASGNAS complex locus | Kartais (5–29%) | 4 ligose |
| GNB1G protein subunit beta 1 | Kartais (5–29%) | 1 ligoje |
| GRIK2glutamate ionotropic receptor kainate type subunit 2 | Kartais (5–29%) | 1 ligoje |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Kartais (5–29%) | 2 ligose |
| GSTM3glutathione S-transferase mu 3 | Kartais (5–29%) | 1 ligoje |
| GUK1guanylate kinase 1 | Kartais (5–29%) | 1 ligoje |
| H1-4H1.4 linker histone, cluster member | Kartais (5–29%) | 1 ligoje |
| HARS1histidyl-tRNA synthetase 1 | Kartais (5–29%) | 1 ligoje |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Kartais (5–29%) | 1 ligoje |
| HEXBhexosaminidase subunit beta | Kartais (5–29%) | 1 ligoje |
| HFEhomeostatic iron regulator | Kartais (5–29%) | 1 ligoje |
| HIVEP2HIVEP zinc finger 2 | Kartais (5–29%) | 1 ligoje |
| HMBShydroxymethylbilane synthase | Kartais (5–29%) | 2 ligose |
| HMOX1heme oxygenase 1 | Kartais (5–29%) | 1 ligoje |
| HSPG2heparan sulfate proteoglycan 2 | Kartais (5–29%) | 1 ligoje |
| HTRA2HtrA serine peptidase 2 | Kartais (5–29%) | 1 ligoje |
| IFNGinterferon gamma | Kartais (5–29%) | 1 ligoje |
| IFT172intraflagellar transport 172 | Kartais (5–29%) | 1 ligoje |
| IFT27intraflagellar transport 27 | Kartais (5–29%) | 1 ligoje |
| IFT74intraflagellar transport 74 | Kartais (5–29%) | 1 ligoje |
| IGF1Rinsulin like growth factor 1 receptor | Kartais (5–29%) | 1 ligoje |
| JRKJrk helix-turn-helix protein | Kartais (5–29%) | 1 ligoje |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Kartais (5–29%) | 1 ligoje |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Kartais (5–29%) | 1 ligoje |
| KMT2Blysine methyltransferase 2B | Kartais (5–29%) | 1 ligoje |
| LAMP2lysosome associated membrane protein 2 | Kartais (5–29%) | 1 ligoje |
| LGI3leucine rich repeat LGI family member 3 | Kartais (5–29%) | 1 ligoje |
| LRRK2leucine rich repeat kinase 2 | Kartais (5–29%) | 1 ligoje |
| LZTFL1leucine zipper transcription factor like 1 | Kartais (5–29%) | 1 ligoje |
| MAMLD1mastermind like domain containing 1 | Kartais (5–29%) | 1 ligoje |
| MAN2B1mannosidase alpha class 2B member 1 | Kartais (5–29%) | 2 ligose |
| MAPK1mitogen-activated protein kinase 1 | Kartais (5–29%) | 1 ligoje |
| MED12Lmediator complex subunit 12L | Kartais (5–29%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Kartais (5–29%) | 1 ligoje |
| MEN1menin 1 | Kartais (5–29%) | 1 ligoje |
| MIFmacrophage migration inhibitory factor | Kartais (5–29%) | 1 ligoje |
| MIR17HGmiR-17-92a-1 cluster host gene | Kartais (5–29%) | 1 ligoje |
| MKKSMKKS centrosomal shuttling protein | Kartais (5–29%) | 1 ligoje |
| MKS1MKS transition zone complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| MYO7Amyosin VIIA | Kartais (5–29%) | 2 ligose |
| MYT1Lmyelin transcription factor 1 like | Kartais (5–29%) | 1 ligoje |
| NAGSN-acetylglutamate synthase | Kartais (5–29%) | 1 ligoje |
| NAXENAD(P)HX epimerase | Kartais (5–29%) | 1 ligoje |
| NEXMIFneurite extension and migration factor | Kartais (5–29%) | 1 ligoje |
| NFIBnuclear factor I B | Kartais (5–29%) | 1 ligoje |
| NOTCH3notch receptor 3 | Kartais (5–29%) | 1 ligoje |
| NPHP1nephrocystin 1 | Kartais (5–29%) | 1 ligoje |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Kartais (5–29%) | 1 ligoje |
| NSD1nuclear receptor binding SET domain protein 1 | Kartais (5–29%) | 1 ligoje |
| OTCornithine transcarbamylase | Kartais (5–29%) | 1 ligoje |
| PAK3p21 (RAC1) activated kinase 3 | Kartais (5–29%) | 1 ligoje |
| PCDH15protocadherin related 15 | Kartais (5–29%) | 1 ligoje |
| PDE10Aphosphodiesterase 10A | Kartais (5–29%) | 1 ligoje |
| PDZD7PDZ domain containing 7 | Kartais (5–29%) | 1 ligoje |
| PINK1PTEN induced kinase 1 | Kartais (5–29%) | 2 ligose |
| PODXLpodocalyxin like | Kartais (5–29%) | 1 ligoje |
| PPM1Dprotein phosphatase, Mg2+/Mn2+ dependent 1D | Kartais (5–29%) | 1 ligoje |
| PRKNparkin RBR E3 ubiquitin protein ligase | Kartais (5–29%) | 1 ligoje |
| PTBP1polypyrimidine tract binding protein 1 | Kartais (5–29%) | 1 ligoje |
| PTPAprotein phosphatase 2 phosphatase activator | Kartais (5–29%) | 1 ligoje |
| PURApurine rich element binding protein A | Kartais (5–29%) | 1 ligoje |
| RFX7regulatory factor X7 | Kartais (5–29%) | 1 ligoje |
| RIMS2regulating synaptic membrane exocytosis 2 | Kartais (5–29%) | 1 ligoje |
| RNF125ring finger protein 125 | Kartais (5–29%) | 1 ligoje |
| RPS6KC1ribosomal protein S6 kinase C1 | Kartais (5–29%) | 1 ligoje |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Kartais (5–29%) | 2 ligose |
| SATB2SATB homeobox 2 | Kartais (5–29%) | 1 ligoje |
| SCAPERS-phase cyclin A associated protein in the ER | Kartais (5–29%) | 1 ligoje |
| SCLT1sodium channel and clathrin linker 1 | Kartais (5–29%) | 1 ligoje |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Kartais (5–29%) | 1 ligoje |
| SERPINA1serpin family A member 1 | Kartais (5–29%) | 1 ligoje |
| SETBP1SET binding protein 1 | Kartais (5–29%) | 1 ligoje |
| SETD1ASET domain containing 1A, histone lysine methyltransferase | Kartais (5–29%) | 1 ligoje |
| SGSM3small G protein signaling modulator 3 | Kartais (5–29%) | 1 ligoje |
| SIN3ASIN3 transcription regulator family member A | Kartais (5–29%) | 1 ligoje |
| SLC11A1solute carrier family 11 member 1 | Kartais (5–29%) | 1 ligoje |
| SLC25A4solute carrier family 25 member 4 | Kartais (5–29%) | 1 ligoje |
| SLC26A9solute carrier family 26 member 9 | Kartais (5–29%) | 1 ligoje |
| SLC4A10solute carrier family 4 member 10 | Kartais (5–29%) | 1 ligoje |
| SLC6A14solute carrier family 6 member 14 | Kartais (5–29%) | 1 ligoje |
| SLC7A6OSsolute carrier family 7 member 6 opposite strand | Kartais (5–29%) | 1 ligoje |
| SLC9A3solute carrier family 9 member A3 | Kartais (5–29%) | 1 ligoje |
| SNCAsynuclein alpha | Kartais (5–29%) | 1 ligoje |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Kartais (5–29%) | 1 ligoje |
| SPARTspartin | Kartais (5–29%) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Kartais (5–29%) | 1 ligoje |
| SRCAPSnf2 related CREBBP activator protein | Kartais (5–29%) | 1 ligoje |
| SRPX2sushi repeat containing protein X-linked 2 | Kartais (5–29%) | 1 ligoje |
| SRRM2serine/arginine repetitive matrix 2 | Kartais (5–29%) | 1 ligoje |
| STEEP1STING1 ER exit protein 1 | Kartais (5–29%) | 1 ligoje |
| STX16syntaxin 16 | Kartais (5–29%) | 1 ligoje |
| SYNJ1synaptojanin 1 | Kartais (5–29%) | 1 ligoje |
| SYT1synaptotagmin 1 | Kartais (5–29%) | 1 ligoje |
| TCF12transcription factor 12 | Kartais (5–29%) | 1 ligoje |
| TGFB1transforming growth factor beta 1 | Kartais (5–29%) | 1 ligoje |
| THOC2THO complex subunit 2 | Kartais (5–29%) | 2 ligose |
| TMEM147transmembrane protein 147 | Kartais (5–29%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Kartais (5–29%) | 1 ligoje |
| TRIM32tripartite motif containing 32 | Kartais (5–29%) | 1 ligoje |
| TRIP12thyroid hormone receptor interactor 12 | Kartais (5–29%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Kartais (5–29%) | 1 ligoje |
| TTC8tetratricopeptide repeat domain 8 | Kartais (5–29%) | 1 ligoje |
| TTRtransthyretin | Kartais (5–29%) | 1 ligoje |
| TWNKtwinkle mtDNA helicase | Kartais (5–29%) | 1 ligoje |
| UCHL1ubiquitin C-terminal hydrolase L1 | Kartais (5–29%) | 1 ligoje |
| USH1CUSH1 protein network component harmonin | Kartais (5–29%) | 1 ligoje |
| USH1GUSH1 protein network component sans | Kartais (5–29%) | 1 ligoje |
| USH2Ausherin | Kartais (5–29%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Kartais (5–29%) | 1 ligoje |
| VPS13Cvacuolar protein sorting 13 homolog C | Kartais (5–29%) | 1 ligoje |
| WDPCPWD repeat containing planar cell polarity effector | Kartais (5–29%) | 1 ligoje |
| WDR45WD repeat domain 45 | Kartais (5–29%) | 1 ligoje |
| WHRNwhirlin | Kartais (5–29%) | 1 ligoje |
| YY1YY1 transcription factor | Kartais (5–29%) | 3 ligose |
| ZBTB20zinc finger and BTB domain containing 20 | Kartais (5–29%) | 1 ligoje |
| ZFXzinc finger protein X-linked | Kartais (5–29%) | 1 ligoje |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Kartais (5–29%) | 1 ligoje |
| CPA6carboxypeptidase A6 | Retai (1–4 %) | 1 ligoje |
| EBF3EBF transcription factor 3 | Retai (1–4 %) | 1 ligoje |
| FA2Hfatty acid 2-hydroxylase | Retai (1–4 %) | 1 ligoje |
| FGF13fibroblast growth factor 13 | Retai (1–4 %) | 1 ligoje |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Retai (1–4 %) | 1 ligoje |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Retai (1–4 %) | 1 ligoje |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Retai (1–4 %) | 1 ligoje |
| PRRT2proline rich transmembrane protein 2 | Retai (1–4 %) | 1 ligoje |
| SLC32A1solute carrier family 32 member 1 | Retai (1–4 %) | 1 ligoje |
| STX1Bsyntaxin 1B | Retai (1–4 %) | 1 ligoje |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Neužfiksuota | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Neužfiksuota | 1 ligoje |
| CLN3CLN3 lysosomal/endosomal transmembrane protein, battenin | Neužfiksuota | 1 ligoje |
| CPOXcoproporphyrinogen oxidase | Neužfiksuota | 1 ligoje |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Neužfiksuota | 1 ligoje |
| HTR2A5-hydroxytryptamine receptor 2A | Neužfiksuota | 1 ligoje |
| JPH3junctophilin 3 | Neužfiksuota | 1 ligoje |
| KMT2Elysine methyltransferase 2E (inactive) | Neužfiksuota | 1 ligoje |
| NFASCneurofascin | Neužfiksuota | 1 ligoje |
| NKX2-1NK2 homeobox 1 | Neužfiksuota | 1 ligoje |
| PAHphenylalanine hydroxylase | Neužfiksuota | 1 ligoje |
| PDE11Aphosphodiesterase 11A | Neužfiksuota | 1 ligoje |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Neužfiksuota | 1 ligoje |
| PQBP1polyglutamine binding protein 1 | Neužfiksuota | 1 ligoje |
| RLIMring finger protein, LIM domain interacting | Neužfiksuota | 1 ligoje |
| SETD2SET domain containing 2, histone lysine methyltransferase | Neužfiksuota | 1 ligoje |
| SLC45A1solute carrier family 45 member 1 | Neužfiksuota | 1 ligoje |
| SLC6A4solute carrier family 6 member 4 | Neužfiksuota | 1 ligoje |
| TCF20transcription factor 20 | Neužfiksuota | 1 ligoje |
| TTC19tetratricopeptide repeat domain 19 | Neužfiksuota | 1 ligoje |
| XKX-linked Kx blood group antigen, Kell and VPS13A binding protein | Neužfiksuota | 1 ligoje |
| YWHAGtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites